NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/07/2025
Back to search
Official data from USPTO
TSURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
04/03/2026
Trademark type
Combined
Nice classes
5, 10
Filing date
09/16/2022
Registration date
07/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/23/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
FR
Examiner
CARR, PATRICK C
Law office
N70
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "TSURE".
Holders and representatives
Holders
S. F. (pessoa física)
Representatives
Charles Ho Barron & Young PLLC
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
diagnostic reagents for medical use; reagents for use in medical genetic testing; medical diagnostic products for bacteriological culturesmedical diagnostic reagents; chemical preparations for pharmaceutical usefor treating infectious diseasesinflammatory and neoplastic diseasesdigestive diseasesrespiratory diseasescirculatory diseasesimmune system diseases; chemical preparations for medical usefor treating infectious diseasesinflammatory and neoplastic diseasesdigestive diseasesrespiratory diseasescirculatory diseasesimmune system diseases; diagnostic preparations for medical use; diagnostic kits for medical diagnostic purposes consisting of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectionfor the detection of cancerinfectious diseasesinflammatory disorders and oncological disorders; purified biochemicalsprotein arraysfluorescent enzymes and dyes for use as reagents for medical diagnostics; chemical reagents for medical and veterinary use; biochemical preparations for medical use being chemical preparations for the diagnosis of pregnancy; diagnostic biomarking reagents for medical use; all of the aforementioned goods are not for use with infusion sets; ointments for pharmaceutical use being antibiotic ointments; antibiotic ointments; anti-inflammatory ointments; medicinal ointments for treating dermatological conditions; food for babies; dietary supplements for humans and animals for the mouth to be taken in the nature of tabletscapsules and gel capsules; dental waxes
Class 10
blood testing apparatus; x-ray diagnostic apparatus; testing apparatus for medical usegenetic testing apparatus for medical purposes; diagnostic imaging apparatus for medical useelectromagnetic medical diagnostic imaging apparatus; apparatus for testing bacteria and virusesmedical diagnostic apparatus for testing for viruses and bacteria; DNA extraction and purification apparatus for medical useapparatus for DNA testing for medical purposes; medical apparatus and instruments for RNA analysisother than for dental useapparatus for RNA testing for medical purposes; body composition analyzers for medical use; diagnostic apparatus for medical and veterinary usein particular for detecting nucleic acid molecules in a samplein particular in a patient samplemedical apparatus and instruments for diagnostic use for testing for hereditary diseasesinfectious diseasesinflammatory and neoplastic diseasesdigestive diseasesrespiratory diseasescirculatory diseasesimmune system diseases; analysis devices for identification of bacteria for medical usemedical instruments for analysing and identifying bacteria; DNA and RNA testing apparatus for medical use; genetic testing apparatus for medical use; medical devicesnucleic acid analyzer for medical diagnosticsmedical apparatus and instruments for diagnostic use for testing for hereditary diseasesinfectious diseasesinflammatory and neoplastic diseasesdigestive diseasesrespiratory diseasescirculatory diseasesimmune system diseases; immunochemical testing apparatus for medical use; all of the aforementioned goods do not consist of infusion setsare not for use with infusion sets
Publications
History of USPTO decisions and trademark events.
42 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/25/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/07/2025
FIMP
FINAL DISPOSITION PROCESSED
01/06/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/23/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/23/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/30/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/07/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/07/2024
GPNX
NOTIFICATION PROCESSED BY IB
05/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2024
PUBO
PUBLISHED FOR OPPOSITION
05/07/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/17/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/17/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/17/2024
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
04/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/15/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/15/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/15/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/13/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/13/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/13/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/13/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/13/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/12/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/02/2024
GNFR
FINAL REFUSAL E-MAILED
01/02/2024
CNFR
FINAL REFUSAL WRITTEN
01/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/27/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/25/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/25/2023
RFNT
REFUSAL PROCESSED BY IB
09/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/11/2023
RFRR
REFUSAL PROCESSED BY MPU
08/11/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/07/2023
CNRT
NON-FINAL ACTION WRITTEN
07/06/2023
DOCK
ASSIGNED TO EXAMINER
06/28/2023
MAFR
APPLICATION FILING RECEIPT MAILED
01/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/30/2022
Continuous trademark protection
Get notified about every new filing that threatens TSURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.